Ai Biosimilars

Research Frontiers in Imbalanced Learning Rare Adverse Event Detection

Developing specialized machine learning techniques for highly imbalanced pharmacovigilance data to detect rare biosimilar adverse events in populations.

All AI Biosimilars PhD categories